Icon price target lowered to $120 from $175 at JPMorgan
JPMorgan lowered the firm’s price target on Icon (ICLR) to $120 from $175 and keeps a Neutral rating on the shares. The firm updated the company’s model. Published first on…
Fiscal Year: January - December
ICON Public Limited Company (ICLR), listed on the NASDAQ, has a market capitalization of $8.67B. As of May 19, 2026, the stock is trading at $113.55 per share@else an unavailable price , offering investors a clear view of its current market value. ICON Public Limited Company is a prominent player in the industry sector, attracting both institutional and retail investors due to its performance and potential.
With a P/E ratio of 15.22, investors can assess the stock's valuation in comparison to its earnings. A P/E ratio is a crucial indicator for value investors, showing whether the stock is over or undervalued relative to its current earnings. ICON Public Limited Company also offers a dividend yield of N/A , making it an attractive option for income-focused investors who seek regular dividends.
Our Discounted Cash Flow (DCF) analysis reveals that ICON Public Limited Company (ICLR) may be undervalued compared to its intrinsic worth. However, to see the exact DCF fair value, please Login or Upgrade for access.
The proprietary SS Score for ICON Public Limited Company is a unique metric that analyzes the company's financial health and growth potential. The score takes into account critical factors such as revenue growth, net income, free cash flow (FCF) compound annual growth rate (CAGR), the trend of shares outstanding, and the debt-to-FCF ratio. This helps investors to make a more informed decision, as an undervalued stock might still have poor financial fundamentals.
To view the detailed SS Score for ICON Public Limited Company, Login or Upgrade for access.
The Price to Free Cash Flow (P/FCF) ratio for ICON Public Limited Company is 9.21, offering insights into how much investors are paying for the company's free cash flow. A lower P/FCF ratio typically suggests that the stock is undervalued, while a higher ratio may indicate overvaluation.
In summary, ICON Public Limited Company (ICLR) has shown consistent financial performance, as illustrated by the financial charts above, which track its revenue growth, net income, free cash flow, and shares outstanding over the past several years. These metrics provide investors with key insights into the company's past and projected future performance. Investors should use the SS Score alongside the DCF Fair Value to make better-informed decisions about whether to buy or hold the stock.
*This analysis is for informational purposes only and does not constitute investment advice. Always read the company's 10-K filings and do your own research before making any investment decisions.
Whether ICON Public Limited Company (ICLR) is a good stock to buy depends on various factors, including its financial health, market conditions, and your investment strategy. Our analysis indicates that the stock may be undervalued compared to its intrinsic value. However, it is important to assess the SS Score and review the company's fundamentals before making any investment decisions.
The fair value of ICON Public Limited Company (ICLR) is determined through our Discounted Cash Flow (DCF) analysis. This value represents the intrinsic worth of the stock based on its expected future cash flows. To view the specific fair value, consider subscribing to our service for complete access.
The SS Score is a proprietary financial quality metric that assesses factors such as revenue growth, net income, free cash flow growth, and debt levels. It helps investors evaluate the overall financial health of ICON Public Limited Company. To access the full SS Score, consider upgrading your subscription.
ICON Public Limited Company is a significant player in the industry sector, with a market capitalization of $8.67B and a competitive P/E ratio of 15.22. Investors should compare these metrics with industry peers to gauge whether ICON Public Limited Company is outperforming or underperforming within its sector.
JPMorgan lowered the firm’s price target on Icon (ICLR) to $120 from $175 and keeps a Neutral rating on the shares. The firm updated the company’s model. Published first on…
RBC Capital analyst Ryan Halsted resumed coverage of Icon (ICLR) with a Sector Perform rating and $123 price target Leading indicators signal a return of clinical trial activity that should…
Icon (ICLR) plc announced the expansion of its early phase capabilities with the opening of a new, state-of-the-art Clinical Research Unit in San Antonio, Texas, as well as new satellite…
DUBLIN & SAN ANTONIO--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced the expansion of its early phase capabilities with the opening of a new,...
Philadelphia, PA, May 05, 2026 (GLOBE NEWSWIRE) -- HealthVerity, Inc., the leader in privacy-protected real-world data exchange and patient identity solutions, today announced that it has entered into...
Leerink analyst Michael Cherny raised the firm’s price target on Icon (ICLR) to $125 from $105 and keeps an Outperform rating on the shares.
ICON (ICLR) announced that the Audit Committee of the Board of Directors has completed its investigation into certain of the Company’s accounting practices and controls. The Company reaffirmed that th...
DUBLIN--(BUSINESS WIRE)--ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results.
Pre-earnings options volume in ICON (ICLR) plc is 2.0x normal with calls leading puts 5:1. Implied volatility suggests the market is anticipating a move near 12.4%, or $12.60, after results…
Pre-earnings options volume in ICON (ICLR) plc is 1.1x normal with puts leading calls 8:5. Implied volatility suggests the market is anticipating a move near 11.5%, or $13.52, after results…
Pre-earnings options volume in ICON (ICLR) plc is normal with calls leading puts 7:5. Implied volatility suggests the market is anticipating a move near 9.7%, or $11.49, after results are…
BMO Capital analyst Sean Dodge upgraded Icon (ICLR) to Outperform from Market Perform with a price target of $130, up from $100. The firm’s recent analysis indicates continued improvements in…
ICON (ICLR) and Advarra have entered a definitive partnership agreement to introduce a new ‘research-ready,’ connected site network model for clinical trials. The partnership will integrate ICON’s glo...
DUBLIN & COLUMBIA, Md.--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, and Advarra, the market leader in regulatory reviews and a leading provider of connect...
NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating ICON PLC (“ICON” or the “Company”) (NASDAQ:...
Pre-earnings options volume in ICON (ICLR) plc is normal with calls leading puts 13:1. Implied volatility suggests the market is anticipating a move near 2.8%, or $2.71, after results are…
Citi analyst Patrick Donnelly lowered the firm’s price target on Icon (ICLR) to $120 from $200 and keeps a Neutral rating on the shares. The firm updated models in the…
Pre-earnings options volume in ICON (ICLR) plc is normal with calls leading puts 19:6. Implied volatility suggests the market is anticipating a move near 4.1%, or $4.44, after results are…
Barclays analyst Luke Sergott lowered the firm’s price target on Icon (ICLR) to $120 from $200 and keeps an Equal Weight rating on the shares. The firm cites uncertainty around…
MILWAUKEE, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating possible securities fraud claims against ICON (NASDAQ: ICLR). The investigation results from inaccurate statements ICON may have...
Jefferies analyst David Windley upgraded Icon (ICLR) to Buy from Hold with a price target of $135, down from $175. The stock’s current valuation makes Icon “hard to ignore,” the…
(NASDAQ: ICLR) NEW YORK, Feb. 18, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating ICON plc (NASDAQ: ICLR) following the company's disclosure on February 12, 2026, that an internal accounti...
TD Cowen analyst Charles Rhyee upgraded Icon (ICLR) to Buy from Hold with a price target of $120, down from $183. The selloff related to the company’s internal accounting investigation…
Rothschild & Co Redburn analyst Jamie Clark downgraded Icon (ICLR) to Neutral from Buy with a price target of $100, down from $226. The firm cites the company’s announcement of…
Shares of Icon were plummeting on Thursday toward their worst day in decades, as the announcement of an accounting probe added to all the pressures the contract research organization sector has alread...
Below estimates were sourced from SimplyWallSt and are intended for educational purposes only as a baseline for the analysis.
| Year | FCF Estimate | % | # Analysts |
|---|---|---|---|
| 2025 | 1.22B | -24.59% | Est @-24.6% |
| 2026 | 0.82B | -32.60% | Analyst x8 |
| 2027 | 0.88B | 6.95% | Analyst x8 |
| 2028 | 0.97B | 10.45% | Analyst x5 |
| 2029 | 0.90B | -7.64% | Analyst x2 |
| 2030 | 0.98B | 9.04% | Analyst x2 |
| 2031 | 1.00B | 2.05% | Est @2.0% |
| 2032 | 1.02B | 2.24% | Est @2.2% |
| 2033 | 1.05B | 2.36% | Est @2.4% |
| 2034 | 1.07B | 2.28% | Est @2.3% |
Below are the FCF estimates with the discount factor and the calculated present value with the terminal value that led the results above.
| Year | FCF | Discount Factor | PV of Future FCF |
|---|---|---|---|
| 2023A | 1.66B | 1.00 | 1.66B |
| 2024A | 1.62B | 1.00 | 1.62B |
| 2025E | 1.22B | 1.09 | 1.12B |
| 2026E | 823.29M | 1.18 | 697.44M |
| 2027E | 880.52M | 1.28 | 686.54M |
| 2028E | 972.56M | 1.39 | 697.95M |
| 2029E | 898.30M | 1.51 | 593.34M |
| 2030E | 979.55M | 1.64 | 595.50M |
| 2031E | 999.61M | 1.79 | 559.32M |
| 2032E | 1.02B | 1.94 | 526.31M |
| 2033E | 1.05B | 2.11 | 495.86M |
| 2034E | 1.07B | 2.29 | 466.80M |
| Terminal | 17.84B | 2.29 | 7.78B |
The information given by Studying Stocks and provided in the web and/or mobile applications (Platforms) is only factual information and should not be considered financial advice.
Any information contained in this website has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
When creating an account, you acknowledge that you are:
We retain the right to cancel your account for any reason, or refuse your account creation request.
The information on our Platforms is not comprehensive and is intended to provide a summary of the subject matter covered. While we use all reasonable attempts to ensure the accuracy and completeness of the data and information on our Platforms, to the extent permitted by law, we make no warranty regarding the information on these Platforms. You should monitor any changes to the information contained on these Platforms.
Furthermore we make no commitments in regards to the minimum amount of uptime that our platforms will maintain, although we will make ever reasonable attempt to ensure that the platforms are operational. Therefore, any reference of "latest", "current" and related words about the financial data presented here may not be up to date with the financial markets or represent reality of the information.
We are not liable to you or anyone else if interference with or damage to your computer systems occurs in connection with the use of these Platforms or a linked website. You must take your own precautions to ensure that whatever you select for your use from our Platforms is free of viruses or anything else (such as worms or Trojan horses) that may interfere with or damage the operations of your computer systems.
We may, from time to time and without notice, change or add to the Platforms (including the Terms) or the information, products or services described in it. However, we do not undertake to keep the Platforms updated. We are not liable to you or anyone else if errors occur in the information or the Platforms is not up-to-date.
Our Platforms may contain links to websites operated by third parties. Those links are provided for convenience and may not remain current or be maintained. Unless expressly stated otherwise, we do not endorse and are not responsible for the content on those linked websites and have no control over or rights in those linked websites.
These Platforms are for your personal, non-commercial use only. You may not modify, copy, distribute, transmit, display, perform, reproduce, publish, license, commercially exploit, create derivative works from, transfer, or sell any Content, software, products or services contained within these Platforms. You may not use these Platforms, or any of its Content, to further any commercial purpose, including any advertising or advertising revenue generation activity on your own website.
You must not do any act that we would deem to be inappropriate, is unlawful or is prohibited by any laws applicable to these Platforms, including but not limited to:
If we allow you to post any information to our Platforms, we have the right to take down this information at our sole discretion and without notice.
To the maximum extent permitted by law, we make no warranties or representations about these Platforms or the Content, including but not limited to warranties or representations that they will be complete, accurate or up-to-date, that access will be uninterrupted or error-free or free from viruses, or that these Platforms will be secure.
We reserve the right to restrict, suspend or terminate without notice your access to these Platforms, any Content, or any feature of these Platforms at any time without notice and we will not be responsible for any loss, cost, damage or liability that may arise as a result.
To the maximum extent permitted by law, in no event shall we be liable for any direct and indirect loss, damage or expense – irrespective of the manner in which it occurs – which may be suffered due to your use of our Platforms and/or the information or materials contained on it, or as a result of the inaccessibility of these Platforms and/or the fact that certain information or materials contained on it are incorrect, incomplete or not up-to-date.
This website utilises cookies. If you do not have cookies enabled in your web browser some functions of the site may not work as intended.